Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4398-4402

  Lim, Pitt O ^a,b,c   Macdonald, Thomas M ^a,b,c   Holloway, Christine ^a,b,c   Friel, Elaine ^a,b,c   Anderson, Niall H ^a,b,c   Dow, Eleanor ^a,b,c   Jung, Roland T ^a,b,c   Davies, Eleanor ^a,b,c   Fraser, Robert ^a,b,c   Connell, John M C ^a,b,c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; RENIN; STEROID 11BETA MONOOXYGENASE; STEROIDOGENIC FACTOR 1;

ADULT; ALLELE; ARTICLE; BINDING SITE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC CODE; GENETIC POLYMORPHISM; HAPLOTYPE; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALDOSTERONE; ALDOSTERONE SYNTHASE; BASE SEQUENCE; BLOOD PRESSURE; CREATININE; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POTASSIUM; RENIN; SODIUM; VARIATION (GENETICS);

EID: 18544362070     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-012070     Document Type: Article

References (23)

1. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM 2000 High prevalence of primary aldosteronism in the Tayside hypertensive clinic population. J Hum Hypertens 14:311-315
2. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353:40
3. Kaplan NM 2001 Cautions over the current epidemic of primary aldosteronism. Lancet 357:953-954
4. Lim PO, Jung RT, MacDonald TM 2002 Is aldosterone the missing link in refractory hypertension? Aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity. J Hum Hypertens 16:153-158
5. Lim PO, Jung RT, MacDonald TM 1999 Raised aldosterone to renin ratio predicts anti-hypertensive efficacy of spironolactone. A prospective cohort follow-up study. Br J Clin Pharmacol 48:756-760
6. Takeda Y, Furukawa K, Inaba S, Miyamori I, Mabuchi H 1999 Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J Clin Endocrinol Metab 84:1633-1637
7. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM 1999 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703-707
8. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A 1998 Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 11:856-860
9. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F 1999 Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34:423-429
10. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE 1997 Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 11:638-649
11. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC 1998 Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97:569-575
12. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-1593
13. Rossi GP, Rossi E, Pavan E, Rosati N, Zecchel R, Semplicini A, Perazzoli F, Pessina AC 1998 Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol (Oxf) 49:713-723
14. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, Takasu N 2000 Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35:699-703
15. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F 1998 Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32:198-204
16. Tamaki S, Iwai N, Tsujita Y, Kinoshita M 1999 Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33:266-270
17. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, Kurzinger S, Doring A, Hense HW, Riegger GA 1999 Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 99:2255-2260
18. Mulatero P, Schiavone D, Fallo F, Rabbia F, Pilon C, Chiandussi L, Pascoe L, Veglio F 2000 CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 35:694-698
19. Regolisti G, Giacchetti G, Lucarelli G, Ronconi V, Arnaldi G, Perazzoli F, Casali A, Negro A, Rossi E, Mantero F 2000 Aldosterone synthase gene polymorphism in idiopathic hyperaldosteronism. J Hypertens 18(Suppl 2): S144
20. White PC, Slutsker L 1995 Haplotype analysis of CYP11B2. Endocr Res 21:437-442
21. Gordon RD, Stowasser M, Tunny TJ, Klemm SA. Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318
22. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC 2001 Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 37:699-705
23. Lim PO, Struthers AD, MacDonald TM 2002 The neurohormonal natural history of essential hypertension: toward primary or tertiary aldosteronism? J Hypertens 20:11-15